Literature DB >> 2008783

Successful treatment of neonatal Citrobacter freundii meningitis with ceftriaxone.

C E Rae1, A Fazio, J P Rosales.   

Abstract

Citrobacter meningitis is an uncommon enteric gram-negative infection that afflicts neonates and young children. Approximately 30 percent of children treated or untreated die from the infection. We report a case of C. freundii meningitis that was resistant to ampicillin and was successfully treated with ceftriaxone, a third-generation cephalosporin. A 13-day-old, full-term baby was admitted to the hospital with a one-day history of fever up to 38.8 degrees C. On admission the infant had a temperature of 39.2 degrees C, pulse of 140 beats/min, and a respiratory rate of 32 breaths/min. Except for a slightly bulging fontanelle, the rest of the physical examination was within normal limits. Complete blood count revealed a white blood cell (WBC) count of 12.5 x 10(9)/L, with 0.66 polymorphonuclear cells, 0.10 bands, 0.18 lymphocytes, and 0.06 monocytes. A stat lumbar puncture showed 10 WBCs per high-power field with gram-negative rods. Empiric therapy with ampicillin 225 mg q12h and gentamicin 11 mg q8h was started. Both antibiotics were discontinued after culture and sensitivity results were positive for C. freundii in the blood and spinal fluid. The patient was successfully treated with nine days of ceftriaxone 250 mg q12h.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2008783     DOI: 10.1177/106002809102500106

Source DB:  PubMed          Journal:  DICP        ISSN: 1042-9611


  2 in total

1.  Unusual microtubule-dependent endocytosis mechanisms triggered by Campylobacter jejuni and Citrobacter freundii.

Authors:  T A Oelschlaeger; P Guerry; D J Kopecko
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

2.  Breast milk urea as a nitrogen source for urease positive Bifidobacterium infantis.

Authors:  Patrick Schimmel; Lennart Kleinjans; Roger S Bongers; Jan Knol; Clara Belzer
Journal:  FEMS Microbiol Ecol       Date:  2021-03-08       Impact factor: 4.194

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.